leadf
logo-loader
viewMetal Tiger PLC

Metal Tiger comments on latest operating results from Cobre Resources

Metal Tiger has an extensive international investment portfolio

Metal Tiger PLC -

Metal Tiger PLC (LON:MTR) has highlighted a new quarterly activities report that has been published by Cobre Ltd (ASX:CBE), a company in which Metal Tiger holds a stake of about 18.8%.

“This has been a strong quarter for Cobre with drilling continuing across the Perrinvale project, demonstrating significant high-grade copper-gold results,” Michael McNeilly, chief executive of Metal Tiger said in a statement.

“Results from the Schwabe prospect have been particularly exciting for Metal Tiger, following the drilling campaign confirming the presence of VHMS mineralisation at the Schwabe prospect as well as indicative results of further mineralisation to the north and south of the prospect. We eagerly await the further assay results from the ongoing drilling campaign and look forward to updating shareholders in the near future.”

Separately, the company also entered into a further equity derivative collar financing arrangement in relation to its shareholding in Sandfire Resources (ASX:SFR). 

Quick facts: Metal Tiger PLC

Price: 24.75 GBX

AIM:MTR
Market: AIM
Market Cap: £37.94 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Metal Tiger PLC named herein, including the promotion by the Company of Metal Tiger PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Morning report: FTSE falls as traders get back to their desks

The FTSE is lower after a long weekend despite UK factory output rising by the fastest pace in more than six years, albeit from a low level as businesses begin to get back to work.  Movers and shakers include AstraZeneca (LON:AZN) which has received EU approval for Imfinzi which is to...

on 1/9/20

2 min read